Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor

Cancer

Volumn 78, Issue 6, 1996, Pages 1195-1202

  Ruà, Savino ^a   Comino, Alberto ^b   Fruttero, Adriana ^a   Torchio, Pierfederico ^c   Bouzari, Hedayat ^d   Taraglio, Stefano ^d   Torchio, Bruno ^d   Capussotti, Lorenzo ^d  

^a City Hospital   (Italy)

^b City Hospital   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d MAURIZIANO HOSPITAL   (Italy)

Author keywords

cirrhosis; DNA flow cytometry; hepatocellular carcinoma; S phase fraction

Indexed keywords

ALPHA FETOPROTEIN; DNA; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR NECROSIS;

ADULT; AGE FACTORS; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL DIVISION; DIPLOIDY; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; FORECASTING; HEPATITIS B SURFACE ANTIGENS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PLOIDIES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; S PHASE; SURVIVAL RATE;

EID: 0029830005     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960915)78:6<1195::AID-CNCR5>3.0.CO;2-9     Document Type: Article

References (32)

1. Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Ito Y, et al. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer 1994;73:1149-54.
2. Ballardini G, Groff P, Zoli M, Bianchi G, Groff P, Zoli M, Bianchi G, Giostra F, Francesconi R, et al. Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation. J Hepatol 1994;20:218-22.
3. Arakawa M, Kage M, Sugihara S, Nakashima T, Suenaga M, Okuda K. Emergence of malignant lesions within an adenomatous nodule in cirrhotic liver: observation in five cases. Gastroenterology 1988;95:1664-6.
4. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991; 22:172-8.
5. Lai CL, Wu PC, Lam KC, Todd D. Histologic prognostic indicators in hepatocellular carcinoma. Cancer 1979;44:1677-85.
6. Franco D, Capussotti L, Smadja C, Bouzari H, Meakins J, Kemeny F, et al. Resection of hepatocellular carcinomas. Results in 72 european patients with cirrhosis. Gastroenterology 1990;98:733-8.
7. Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, et al. Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 1990;65:1104-10.
8. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after epatectomy: univariate and multivariate analyses. Hepatology 1991;14:802-5.
9. Fujimoto J, Okamoto E, Yamanaka N, Toyosaka A, Mitsunobu M. Flow cytometric DNA analysis of hepatocellular carcinoma. Cancer 1991;67:939-44.
10. Arii S, Tanaka J, Yamazoe Y, Minematsu S, Morino T, Fujita K, et al. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992;69:913-9.
11. Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992;16:1367-71.
12. Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994; 106:1618-24.
13. Cong WM, Wu MC. The biopathologic characteristics of DNA content of hepatocellular carcinomas. Cancer 1990; 66:498-501.
14. Anti M, Marra G, Rapaccini GL, Rumi C, Bussa S, Fadda G, et al. DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy. Cancer 1994;73: 281-8.
15. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918-28.
16. Kanai T, Hirohashi S, Upton MP, Noguchi M, Kishi K, Makuuchi M, et al. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 1987; 60:810-9.
17. Nakashima S, Okuda K, Kojiro M, Jimi A, Yamaguchi R, Sakamoto K, et al. Pathology of hepatocellular carcinoma in Japan. 232 consecutive cases autopsied in ten years. Cancer 1983;51:863-77.
18. Edmonson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503.
19. Stephenson RA, Gay H, Fair WR, Melamed MR. Effect of section thickness on quality of flow cytometric DNA content determinations in paraffin-embedded tissue. Cytometry 1986;7:41-4.
20. Coon JS, Landay AL, Weinstein RS. Flow cytometric analysis of paraffin-embedded tumors: implications for diagnostic pathology. Hum Pathol 1986;117:435-7.
21. Medley DW, Friedlander ML, Taylor JW, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
22. Hedley DW, Friedlander ML, Taylor IW. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 1985;6:327-33.
23. Joensuu H, Klemi PJ. Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma. Am J Clin Pathol 1988;89:35-40.
24. Kallioniemi OP, Blanco G, Alavaikko M, Hietanen T, Mattila J, Lauslahti K, et al. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: a proposed classification of DNA histograms in breast cancer. Cancer 1988;62:2183-90.
25. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JASA 1958;53:457-81.
26. SAS Institute Inc. SAS/STAT User's Guide. Version 6. 4th ed., Cary (NC): SAS Institute Inc., 1989.
27. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
28. Cox DR. Regression models and life tables. J R Stat Soc 1972;B33:187-220.
29. SAS Technical Report P-229 SAS/STAT software. Changes and enhancements. Release 6.07. 1992:433-79.
30. Saeter G, Lee CZ, Schwarze E, Ous S, Chen DS, Sung JL, et al. Changes in ploidy distributions in human liver carcinogenesis. JNCI 1988;80:1480-5.
31. Scott RJ, Chakraborty S, Sell S, Hunt JM, Dunsford HA. Change in the ploidy state of rat liver cells during chemical hepatocarcinogenesis and its relationship to the increased expression of α-fetoprotein. Cancer Res 1989;49:6085-90.
32. Hamazaki K, Kato T, Yunoki Y, Mori M, Gochi A, Mimura H, et al. An analysis of DNA ploidy pattern of hepatocellular carcinoma. Acta Med Okayama 1993;47:413-6.